Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Applied Therapeutics, Inc. - Common Stock
(NQ:
APLT
)
0.2700
-0.6401 (-70.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Applied Therapeutics, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
↗
February 28, 2024
Applied Therapeutics surges as FDA grants Priority Review to govorestat (AT-007) for Galactosemia treatment. If approved, it would be the first medication for Galactosemia. APLT also submits MAA to...
Via
Benzinga
Why Is Coupang (CPNG) Stock Up 4% Today?
↗
February 28, 2024
Coupang stock is rallying on Wednesday as investors in CPNG celebrate the company beating out EPS and revenue estimates for Q4.
Via
InvestorPlace
Applied Therapeutics Inc. (NASDAQ: APLT) Records 52-Week High Wednesday Morning
February 28, 2024
Via
Investor Brand Network
Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
↗
February 28, 2024
Applied Therapeutics stock is rising higher on Wednesday alongside heavy trading of APLT following an update from the FDA.
Via
InvestorPlace
Applied Therapeutics Announces $100 Million Private Placement
February 28, 2024
From
Applied Therapeutics
Via
GlobeNewswire
(APLT) - Analyzing Applied Therapeutics's Short Interest
↗
January 25, 2024
Via
Benzinga
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
February 28, 2024
From
Applied Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
February 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 16, 2024
Via
Benzinga
Why Is Rare Disease-Focused Applied Therapeutics Stock Trading Higher Today?
↗
February 15, 2024
Results of Applied Therapeutics' Phase 3 INSPIRE trial for oral govorestat (AT-007). Govorestat demonstrates significant sorbitol reduction, improving mobility and overall well-being in SORD Deficiency...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
February 15, 2024
Via
Benzinga
Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency
February 15, 2024
From
Applied Therapeutics
Via
GlobeNewswire
Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales
↗
January 05, 2024
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P...
Via
Benzinga
Topics
Stocks
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
January 05, 2024
Shares of Applied Therapeutics, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
January 05, 2024
Via
Benzinga
Dow Turns Lower; ISM Services PMI Falls In December
↗
January 05, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P...
Via
Benzinga
Topics
Stocks
Applied Therapeutics' Diabetes-Associated Heart Disease Drug Fails In Phase 3 Study, Stock Plunges
↗
January 05, 2024
Applied Therapeutics Inc (NASDAQ: APLT) released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of
Via
Benzinga
Intellia Therapeutics Layoffs 2024: What to Know About the Latest NTLA Job Cuts
↗
January 05, 2024
Intellia Therapeutics layoffs are in the news on Friday as the biotech company prepares to cut its total workforce by 15% to reduce costs.
Via
InvestorPlace
Topics
Workforce
US Stocks Higher; Payrolls Increase By 216,000 In December
↗
January 05, 2024
U.S. stocks traded higher this morning, following the release of jobs data on Friday. Following the market opening Friday, the Dow traded up 0.08% to 37,470.26 while the NASDAQ rose 0.20% to 14,539.40....
Via
Benzinga
Topics
Stocks
Why Is Safe and Green Development (SGD) Stock Up 50% Today?
↗
January 05, 2024
Safe and Green Development stock is up on Friday as investors in SGD celebrate the company's plans to acquire Majestic World Holdings.
Via
InvestorPlace
Why Is Applied Therapeutics (APLT) Stock Down 30% Today?
↗
January 05, 2024
Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
January 05, 2024
Via
Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
↗
January 05, 2024
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...
Via
Benzinga
Topics
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
January 05, 2024
Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!
Via
InvestorPlace
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
January 05, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday.
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 04, 2024
Via
Benzinga
Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
January 04, 2024
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia
January 03, 2024
From
Applied Therapeutics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
December 19, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
↗
December 08, 2023
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
